Friday, January 11, 2019 3:26:20 PM
I reached out to the company and confirmed that there is no reverse split. I was informed by the company that the only way that VYST would do a reverse split would be if they needed to do a small one to meet NASDAQ requirements which was why such was given an honorable mention within their last 10-Q:
https://www.otcmarkets.com/filing/html?id=13070644&guid=kjy8UWUD04sjm3h
I was also informed that if such is the case, VYST would announce a no higher than a 1-10 reverse split at the same time of announcing their application submission to trade on the NASDAQ. If such was to happen, it would be after their upcoming closing of their acquisition of Rotmans that was listed within their last 10-Q under Note 12 Subsequent Events which would immediately make them a NASDAQ company because of the Revenues and Profits that they are generating:
https://www.otcmarkets.com/filing/html?id=13070644&guid=kjy8UWUD04sjm3h
The company totally understands that a reverse split is not good for the market and would never do such unless VYST needed to meet the NASDAQ requirement of having a minimum $4.00 Bid. Based on the logic from my conversation and the ratio of no higher than a 1-10, they plan to see VYST trading at .50+ per share before such is needed to graduate the company to the NASDAQ or a reverse split would never happen. The company also told me that there will be a share buyback in the near future.
To reiterate… The company informed me that they are going to qualify for NASDAQ with their Revenue and that if they ever did a reverse split, they would be filing for the NASDAQ and a small 1-10 reverse split on the same day.
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.
Recent VYST News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/06/2024 09:17:28 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:55:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 09:23:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 05:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM